Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma
NCT00174746
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1145
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
AVE2635A
Sponsor
Sanofi